N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides As Novel Selective Human Cannabinoid Type 2 Receptor (hcb2r) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation
Molecules（2022）
关键词
cannabinoid receptors,hCB2R selective ligands,drug design,in silico simulations,mechanism of receptor activation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要